HPV Ends Here: Increasing Uptake of the HPV Vaccine

Running, not enrolling · Not applicable

Conditions studied: HPV Vaccine

In brief

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Key facts

Study ID

NCT06831929

Run by

University of California, Davis

People needed

2232

Starts

2025-02-28

Expected to finish

2026-12-31

Last updated by the study team

2026-07-17

Who can join

Age: 10 and older, up to 12. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine

You may not qualify if…

• Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.

Where it is running

• University of California Davis Health — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.